Keloid Treatment Market Research Report Information By Product (Elastic Wraps, Ointment), by Treatment (Radiation Therapy, Cry Therapy, Surgical Treatment, Laser Treatment, Laser Treatment, Interferon), by End-User (Hospitals and Others)—Forecast till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Keloid Treatment Market, by Product

6.1 Introduction

6.2 Elastic Wraps

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4 Sprays

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5 Ointment

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.6 Creams

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.7 Oils

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.8 Topical Gels & Gel Sheets

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Keloid Treatment Market, by Treatment

7.1 Introduction

7.2 Ligature

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Radiation Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4 Cryo Therapy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5 Surgical Treatment

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6 Laser Treatment

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.7 Steroid Injections

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.8 Corticosteroid injections (intralesional steroids)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.9 Silicone gel or sheeting

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.10 Interferon

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8. Global Keloid Treatment Market, by End User

8.1 Introduction

8.2 Dermatology Clinics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Hospitals

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9. Global Keloid Treatment Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Novartis AG

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 RXi Pharmaceuticals, Inc

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Sonoma Pharmaceuticals, Inc

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Bristol-Myers Squibb

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Pacific World Corporation

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Valeant Pharmaceuticals International, Inc

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Revitol Corporation

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Avita Medical Limited

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.8 Sensus Healthcare

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Perrigo Company plc

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Keloid Treatment Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Keloid Treatment Market Synopsis, 2020–2027

Table 2 Global Keloid Treatment Market Estimates and Forecast, 2020–2027

(USD Million)

Table 3 Global Keloid Treatment Market, by Region, 2020–2027 (USD Million)

Table 4 Global Keloid Treatment Market, by Product, 2020–2027 (USD Million)

Table 5 Global Keloid Treatment Market, by Treatment, 2020–2027(USD Million)

Table 6 Global Keloid Treatment Market, by End User, 2020–2027 (USD Million)

Table 7 North America: Keloid Treatment Market, by Product, 2020–2027 (USD Million)

Table 8 North America: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)

Table 9 North America: Keloid Treatment Market, by End User, 2020–2027 (USD Million)

Table 10 US: Keloid Treatment Market, by Product, 2020–2027 (USD Million)

Table 11 US: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)

Table 12 US: Keloid Treatment Market, by End User, 2020–2027 (USD Million)

Table 13 Canada: Keloid Treatment Market, by Product, 2020–2027 (USD Million)

Table 14 Canada: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)

Table 15 Canada: Keloid Treatment Market, by End User, 2020–2027 (USD Million)

Table 16 South America: Keloid Treatment Market, by Product, 2020–2027 (USD

Million)

Table 17 South America: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)

Table 18 South America: Keloid Treatment Market, by End User, 2020–2027 (USD Million)

Table 19 Europe: Keloid Treatment Market, by Product, 2020–2027 (USD Million)

Table 20 Europe: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)

Table 21 Europe: Keloid Treatment Market, by End User, 2020–2027 (USD Million)

Table 22 Western Europe: Keloid Treatment Market, by Product, 2020–2027 (USD Million)

Table 23 Western Europe: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)

Table 24 Western Europe: Keloid Treatment Market, by End User, 2020–2027 (USD Million)

Table 25 Eastern Europe: Keloid Treatment Market, by Product, 2020–2027 (USD Million)

Table 26 Eastern Europe: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)

Table 27 Eastern Europe: Keloid Treatment Market, by End User, 2020–2027(USD Million)

Table 28 Asia-Pacific: Keloid Treatment Market, by Product, 2020–2027 (USD Million)

Table 29 Asia-Pacific: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)

Table 30 Asia-Pacific: Keloid Treatment Market, by End User, 2020–2027 (USD Million)

Table 31 Middle East & Africa: Keloid Treatment Market, by Product, 2020–2027 (USD Million)

Table 32 Middle East & Africa: Keloid Treatment Market, by Treatment, 2020–2027 (USD Million)

Table 33 Middle East & Africa: Keloid Treatment Market, by End User, 2020–2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Keloid Treatment Market

Figure 3 Segmentation Market Dynamics for Global Keloid Treatment Market

Figure 4 Global Keloid Treatment Market Share, by Product, 2020

Figure 5 Global Keloid Treatment Market Share, by Treatment, 2020

Figure 6 Global Keloid Treatment Market Share, by End User, 2020

Figure 7 Global Keloid Treatment Market Share, by Region, 2020

Figure 8 North America: Keloid Treatment Market Share, by Country, 2020

Figure 9 Europe: Keloid Treatment Market Share, by Country, 2020

Figure 10 Asia-Pacific: Keloid Treatment Market Share, by Country, 2020

Figure 11 Middle East & Africa: Keloid Treatment Market Share, by Country, 2020

Figure 12 Global Keloid Treatment Market: Company Share Analysis, 2020 (%)

Figure 13 Novartis AG: Key Financials

Figure 14 Novartis AG: Segmental Revenue

Figure 15 Novartis AG: Geographical Revenue

Figure 16 RXi Pharmaceuticals, Inc: Key Financials

Figure 17 RXi Pharmaceuticals, Inc: Segmental Revenue

Figure 18 RXi Pharmaceuticals, Inc: Geographical Revenue

Figure 19 Sonoma Pharmaceuticals, Inc: Key Financials

Figure 20 Sonoma Pharmaceuticals, Inc: Segmental Revenue

Figure 21 Sonoma Pharmaceuticals, Inc: Geographical Revenue

Figure 22 Bristol-Myers Squibb : Key Financials

Figure 23 Bristol-Myers Squibb : Segmental Revenue

Figure 24 Bristol-Myers Squibb : Geographical Revenue

Figure 25 Pacific World Corporation: Key Financials

Figure 26 Pacific World Corporation: Segmental Revenue

Figure 27 Pacific World Corporation. Geographical Revenue

Figure 28 Valeant Pharmaceuticals International, Inc: Key Financials

Figure 29 Valeant Pharmaceuticals International, Inc: Segmental Revenue

Figure 30 Valeant Pharmaceuticals International, Inc: Geographical Revenue

Figure 31 Revitol Corporation: Key Financials

Figure 32 Revitol Corporation: Segmental Revenue

Figure 33 Revitol Corporation: Geographical Revenue

Figure 34 Avita Medical Limited: Key Financials

Figure 35 Avita Medical Limited: Segmental Revenue

Figure 36 Avita Medical Limited: Geographical Revenue

Figure 37 Sensus Healthcare: Key Financials

Figure 38 Sensus Healthcare: Segmental Revenue

Figure 39 Sensus Healthcare: Geographical Revenue

Figure 40 Perrigo Company plc: Key Financials

Figure 41 Perrigo Company plc: Segmental Revenue

Figure 42 Perrigo Company plc: Geographical Revenue